Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
Go back to Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse| Elite Pharmaceuticals, Inc. (AMEX: ELTP) | Delayed: 0.37 +0.01 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $0.42 | |||
| Open | $0.36 | 52 Week Low | $0.11 | |||
| Day High | $0.37 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $-0.02 | |||
| Volume | 111,993 | |||||
